Description

Bu uygulama UCB Pharma tarafındanverilensınırsız bir eğitim bursu çerçevesinde nöroloji ve çocuknörolojisihekimlerine bilimsel destek amacıylahazırlanmıştır.
İçindeki bilgiler aralıklı olarak güncellenmekle birlikte ensontıbbi gelişmeleri içermeyebilir.
Lütfen en son gelişmeler için tıbbi bilgi kaynaklarına başvurunuzveürünü reçete etmeden önce, lütfen prospektüsbilgisinebakınız.
Burada yer alan bütün beyanatlar ve fikirler editörlere veözgünyazarlarına aittir; sponsor için bağlayıcı değildir.

This application is a medical guide for drug-drug interactioninepilepsy treatment, targeting neurologists in Turkey only.Theinformation is scientific, referencing peer reviewedmedicalliterature and approved by UCB Pharma local medicalreviewcommittee. This guide has been used for 5 years as a printedform.Application will be distributed only to neurologists by UCBPharmaresources in Turkey. Application also includes a dose guideandinformation on drugs which alter seizure threshold.

This application toUCBPharma in the framework of an unlimited educational grantprovidedby neurology and child neurology physician is preparedtoscientific support.
Contents may not contain information is updated with thelatestmedical developments, although intermittently.
Please consult the medical information resource for thelatestdevelopments before prescribing and product informationpleaserefer to the prospectus.
All statements contained herein are owned by the originalauthorsand editors and ideas; It is not binding for sponsors.

This application is a medical guide for drug-drug interactioninepilepsy treatment, targeting Neurologists in Turkey only.Theinformation is scientific, peer reviewed medicalliteraturereferencing and approved by UCB Pharma local medicalreviewcommittee. This guide has been used for 5 years as a printedform.Application will be distributed only to Neurologists by UCBPharmaResources in Turkey. Application also includes a dose guideandinformation on drugs which alter seizure threshold.